NSQIP IBD

1. Read the dataset

Steps to read dataset:

Warning: package 'dplyr' was built under R version 4.5.2

Attaching package: 'dplyr'
The following objects are masked from 'package:stats':

    filter, lag
The following objects are masked from 'package:base':

    intersect, setdiff, setequal, union
Warning: package 'gt' was built under R version 4.5.2
Warning: package 'gtsummary' was built under R version 4.5.2

2. Inclusion & Exclusion Criteria

Inclusion

  • ≥18 years old 2017-2024

  • diagnosed with ulcerative colitis (K51.0) (n=3014)

  • Had CPT codes included below (n=2500)

Exclusion Criteria

  • missing/unknown race or ethnicity (n=219)

  • missing/unclassifiable ileostomy formation (n=265)

3. Baseline Information

  • Dates: 3/1/2017-3/8/2024
[1] "Date"
[1] "2017-03-01" "2024-03-08"
  • Total procedures included: 2500

  • Breakdown of procedure type:

    • RPC with IPAA: 886

    • TAC with end ileostomy: 1228

    • Total proctocolectomy with end ileostomy: 386


  TAC-EI RPC-IPAA   TPC-EI 
    1228      886      386 
  • CPT breakdown within procedure type: (**double check 45395 should fall under RPC IPAA and not TAC EI, have it under TAC EI for now**)

    Procedure Type CPT Procedure
    RPC IPAA 44157 Colectomy, total, abdominal, with proctectomy; with ileoanal anastomosis, includes loop ileostomy, and rectal mucosectomy, when performed
    44158 Colectomy, total, abdominal, with proctectomy; with ileoanal anastomosis, creation of ileal reservoir (S or J), includes loop ileostomy, and rectal mucosectomy, when performed
    44211 Laparoscopy, surgical; colectomy, total, abdominal, with proctectomy, with ileoanal anastomosis, creation of ileal reservoir (S or J), with loop ileostomy, includes rectal mucosectomy, when performed
    45113 Proctectomy, partial, with rectal mucosectomy, ileoanal anastomosis, creation of ileal reservoir (S or J), with or without loop ileostomy
    45397 Laparoscopy, surgical; proctectomy, combined abdominoperineal pull-through procedure (eg, colo-anal anastomosis), with creation of colonic reservoir (eg, J-pouch), with diverting enterostomy, when performed
    TAC EI 44150 Colectomy, total, abdominal, without proctectomy; with ileostomy or ileoproctostomy
    44151 Colectomy, total, abdominal, without proctectomy; with continent ileostomy
    44210 Laparoscopy, surgical; colectomy, total, abdominal, without proctectomy, with ileostomy or ileoproctostomy
    TPC EI/Non restorative proctectomy 44156 Colectomy, total, abdominal, with proctectomy; with continent ileostomy
    44212 Laparoscopy, surgical; colectomy, total, abdominal, with proctectomy, with ileostomy
    44155 Colectomy, total, abdominal, with proctectomy; with ileostomy
    45395 Laparoscopy, surgical; proctectomy, complete, combined abdominoperineal, with colostomy

4. Ileostomy Formation Variable

Using variable ileostomy_formation to see further information on ileostomy. Have several answer choices for this: conversion of end to loop, ibd_ileost, ileostomy from prior is unaltered, new ileostomy, new stoma, none, other ileostomy revision, n/a


Conversion of end ileostomy to loop                          ibd_ileost 
                                563                                  27 
  Ileostomy from prior is unaltered                       New ileostomy 
                                113                                1446 
                          New stoma                                None 
                                  1                                  51 
           Other ileostomy revision                                <NA> 
                                 47                                 252 

5. Defining Staged Procedures

First look at breakdown of how ileostomy_formation is coded against CPT codes

Definitions

  • 1-Stage RPC-IPAA (Proctocolectomy + IPAA without diverting ileostomy):

    • CPT: Total proctocolectomy with IPAA (44157, 44158, 44211).

    • ileostomy_formation: "none" (no loop ileostomy at the time of pouch creation)

  • 2-Stage RPC-IPAA (Proctocolectomy + IPAA with diverting loop ileostomy):

    • CPT: Total proctocolectomy with IPAA (44157, 44158, 44211).

    • ileostomy_formation: "new ileostomy" or "new stoma" (Stage 1 of a 2-stage procedure; Stage 2 is the later ileostomy reversal)

  • 3-Stage Approach -> Stage 1 (Subtotal/Total Abdominal Colectomy with End Ileostomy, TAC-EI):

    • CPT: 44150, 44151, 44210.

    • ileostomy_formation: "new ileostomy" or "new stoma". (patient undergoing TAC-EI is starting either a 3-stage or a modified 2-stage pathway. In single-encounter NSQIP data, TAC-EI represents the initial staged colectomy)

  • 3-Stage Approach -> Stage 2 (Completion Proctectomy + IPAA with diverting loop ileostomy):

    • CPT: Completion proctectomy with IPAA (45113, 45397)

    • ileostomy_formation: "conversion of end to loop", "new ileostomy", or "ileostomy from prior is unaltered" (if kept diverted)

  • Modified 2-Stage Approach — Stage 2 (Completion Proctectomy + IPAA without diverting ileostomy):

    • CPT: Completion proctectomy with IPAA (45113, 45397).

    • ileostomy_formation: "none" (prior end ileostomy taken down and anastomosed the pouch without creating a new diverting stoma)

  • Non-Restorative Surgery (Total Proctocolectomy with Permanent End Ileostomy, TPC-EI):

    • CPT: 44155, 44156, 44212, or 45395 (APR with colostomy).

    • assumed not a staged IPAA- have permanent end ileostomy or colostomy

Visual Diagram of Procedure Breakdown

flowchart TD
    Start["<b>NSQIP IBD Surgical Cohort</b><br/>Classify by Primary CPT &amp; ileostomy_formation"] --> CPT1["<b>Total Proctocolectomy + IPAA</b><br/>CPT: 44157, 44158, 44211"]
    Start --> CPT2["<b>Subtotal / Total Colectomy</b><br/>CPT: 44150, 44151, 44210"]
    Start --> CPT3["<b>Completion Proctectomy + IPAA</b><br/>CPT: 45113, 45397"]
    Start --> CPT4["<b>Total Proctocolectomy / APR</b><br/>CPT: 44155, 44156, 44212, 45395"]

    CPT1 --> Ileo1A{"ileostomy_formation"}
    Ileo1A -- "'none'" --> Out1["<b>1-Stage RPC-IPAA</b><br/>Proctocolectomy + IPAA<br/><i>No diverting loop ileostomy</i>"]
    Ileo1A -- "'new ileostomy' /<br/>'new stoma'" --> Out2["<b>2-Stage RPC-IPAA (Stage 1)</b><br/>Proctocolectomy + IPAA<br/><i>With diverting loop ileostomy</i>"]

    CPT2 --> Ileo2{"ileostomy_formation"}
    Ileo2 -- "'new ileostomy' /<br/>'new stoma'" --> Out3["<b>3-Stage or Modified 2-Stage (Stage 1)</b><br/>TAC-EI: Initial staged colectomy<br/><i>With end ileostomy</i>"]

    CPT3 --> Ileo3{"ileostomy_formation"}
    Ileo3 -- "'conversion of end to loop' /<br/>'new ileostomy' / 'unaltered'" --> Out4["<b>3-Stage Approach (Stage 2)</b><br/>Completion Proctectomy + IPAA<br/><i>With diverting loop ileostomy</i>"]
    Ileo3 -- "'none'" --> Out5["<b>Modified 2-Stage (Stage 2)</b><br/>Completion Proctectomy + IPAA<br/><i>End ileostomy taken down; no diversion</i>"]

    CPT4 --> Out6["<b>Non-Restorative Surgery (TPC-EI)</b><br/>Permanent end ileostomy or colostomy<br/><i>Not a staged IPAA pathway</i>"]

    classDef cpt fill:#e8f1f8,stroke:#2b6cb0,stroke-width:1.5px,color:#1a202c
    classDef restorative fill:#e6fffa,stroke:#2c7a7b,stroke-width:1.5px,color:#1a202c
    classDef nonrestorative fill:#fff5f5,stroke:#c53030,stroke-width:1.5px,color:#1a202c

    class CPT1,CPT2,CPT3,CPT4 cpt
    class Out1,Out2,Out3,Out4,Out5 restorative
    class Out6 nonrestorative

Characteristic

level

Overall

White

URM

Asian

p

test

n

2281

1954

277

50

Age at surgery, years (mean (SD))

42.85 (16.87)

43.21 (16.99)

40.36 (15.85)

42.49 (16.64)

0.030

Sex (%)

Female

631 (44.5)

540 (44.0)

80 (51.9)

11 (31.4)

0.049

Male

786 (55.5)

688 (56.0)

74 (48.1)

24 (68.6)

BMI, kg/m² (mean (SD))

25.42 (5.75)

25.37 (5.54)

26.27 (7.07)

22.71 (4.80)

<0.001

Diabetes mellitus (%)

Insulin

65 (2.8)

49 (2.5)

12 (4.3)

4 (8.0)

0.058

No

2140 (93.8)

1837 (94.0)

259 (93.5)

44 (88.0)

Non-Insulin

76 (3.3)

68 (3.5)

6 (2.2)

2 (4.0)

Hypertension requiring medication (%)

No

1920 (84.2)

1640 (83.9)

240 (86.6)

40 (80.0)

0.366

Yes

361 (15.8)

314 (16.1)

37 (13.4)

10 (20.0)

Current smoker (within 1 year) (%)

No

2150 (94.3)

1842 (94.3)

259 (93.5)

49 (98.0)

0.452

Yes

131 (5.7)

112 (5.7)

18 (6.5)

1 (2.0)

ASA classification (%)

ASA 1 - No Disturb

8 (0.4)

7 (0.4)

1 (0.4)

0 (0.0)

0.002

ASA 2 - Mild Disturb

1127 (49.4)

976 (49.9)

130 (46.9)

21 (42.0)

ASA 3 - Severe Disturb

1087 (47.7)

921 (47.1)

139 (50.2)

27 (54.0)

ASA 4 - Life Threat

56 (2.5)

49 (2.5)

6 (2.2)

1 (2.0)

ASA 5 - Moribund

2 (0.1)

0 (0.0)

1 (0.4)

1 (2.0)

None assigned

1 (0.0)

1 (0.1)

0 (0.0)

0 (0.0)

Biologic therapy (within 60 days) (%)

Cannot be determined

27 (1.3)

23 (1.3)

1 (0.4)

3 (6.5)

0.005

No

1129 (54.8)

964 (54.7)

135 (53.6)

30 (65.2)

Yes

904 (43.9)

775 (44.0)

116 (46.0)

13 (28.3)

Immunomodulator use (within 60 days) (%)

Cannot be determined

20 (1.0)

17 (1.0)

2 (0.8)

1 (2.2)

0.880

No

1839 (89.8)

1576 (90.0)

223 (89.2)

40 (87.0)

Yes

188 (9.2)

158 (9.0)

25 (10.0)

5 (10.9)

Elective surgery (%)

No

312 (22.9)

263 (22.2)

43 (30.1)

6 (17.6)

0.083

Yes

1048 (77.1)

920 (77.8)

100 (69.9)

28 (82.4)

Broad procedure category (Tier 1) (%)

TAC-EI

1095 (48.0)

919 (47.0)

156 (56.3)

20 (40.0)

0.015

RPC-IPAA

816 (35.8)

703 (36.0)

91 (32.9)

22 (44.0)

TPC-EI

370 (16.2)

332 (17.0)

30 (10.8)

8 (16.0)

Granular staged pathway (Tier 2) (%)

TAC-EI (Stage 1 Staged Colectomy)

966 (47.9)

812 (47.0)

137 (56.1)

17 (37.8)

0.002

exact (sim)

Classic 2-Stage RPC-IPAA

102 (5.1)

92 (5.3)

5 (2.0)

5 (11.1)

3-Stage Completion IPAA

616 (30.6)

523 (30.3)

78 (32.0)

15 (33.3)

1-Stage RPC-IPAA

5 (0.2)

4 (0.2)

0 (0.0)

1 (2.2)

Modified 2-Stage Completion IPAA

4 (0.2)

4 (0.2)

0 (0.0)

0 (0.0)

TPC-EI (Permanent Ostomy)

323 (16.0)

292 (16.9)

24 (9.8)

7 (15.6)

Flowchart to see how everything was further broken down:

flowchart TD
    Raw["<b>Initial Dataset</b><br/>N = 8,304"] --> UCExcl["Excluded: Non-UC Diagnosis<br/>(n = 5,290)"]
    Raw --> UC["<b>Ulcerative Colitis Cohort</b><br/>n = 3,014"]
    UC --> CPTExcl["Excluded: Non-Study CPT Codes<br/>(n = 514)"]
    UC --> A["<b>Initial ACS-NSQIP UC Cohort</b><br/>N = 2,500"]

    A --> B["Excluded: Unknown / Unreported<br/>Race or Ethnicity (n = 219)"]
    A --> C["<b>Primary Analytic Cohort (Tier 1)</b><br/>N = 2,281<br/><i>White: 1,954 | URM: 277 | Asian: 50</i>"]
    
    C --> D["<b>TAC-EI</b><br/>CPT 44150, 44151, 44210<br/>n = 1,095 (48.0%)"]
    C --> E["<b>RPC-IPAA</b><br/>CPT 44157, 44158, 44211,<br/>45113, 45397<br/>n = 816 (35.8%)"]
    C --> F["<b>TPC-EI / Non-Restorative</b><br/>CPT 44155, 44156, 44212, 45395<br/>n = 370 (16.2%)"]
    
    D --> D1["Excluded: Missing or 'ibd_ileost'<br/>ileostomy_formation (n = 129)"]
    D --> D2["<b>Stage 1: Initial Staged Colectomy</b><br/><i>(3-Stage or Modified 2-Stage Pathway)</i><br/>TAC-EI + End Ileostomy (n = 966)"]
    
    E --> G["Excluded: Missing or 'ibd_ileost'<br/>ileostomy_formation (n = 89)"]
    E --> H["<b>Restorative IPAA Cohort (Tier 2)</b><br/>n = 727"]
    
    H --> I["<b>Classic 2-Stage RPC-IPAA</b><br/>Primary IPAA + New Loop Ileostomy<br/>n = 102"]
    H --> J["<b>3-Stage Approach (Stage 2)</b><br/>Completion IPAA + Diverting Ileostomy<br/>n = 616"]
    H --> K["<b>1-Stage RPC-IPAA</b><br/>Primary IPAA, No Ileostomy<br/>n = 5"]
    H --> L["<b>Modified 2-Stage (Stage 2)</b><br/>Completion IPAA, No Ileostomy<br/>n = 4"]
    
    F --> F1["Excluded: Missing or 'ibd_ileost'<br/>ileostomy_formation (n = 47)"]
    F --> F2["<b>Non-Restorative Permanent Ostomy</b><br/>TPC-EI / Completion Proctectomy<br/>n = 323"]

    style Raw fill:#f4f6f9,stroke:#2c3e50,stroke-width:2px
    style UC fill:#f4f6f9,stroke:#2c3e50,stroke-width:2px
    style UCExcl fill:#fdf2e9,stroke:#d35400,stroke-dasharray: 5 5
    style CPTExcl fill:#fdf2e9,stroke:#d35400,stroke-dasharray: 5 5
    style A fill:#f4f6f9,stroke:#2c3e50,stroke-width:2px
    style C fill:#e8f4f8,stroke:#1f618d,stroke-width:2px
    style H fill:#e8f4f8,stroke:#1f618d,stroke-width:2px
    style B fill:#fdf2e9,stroke:#d35400,stroke-dasharray: 5 5
    style D1 fill:#fdf2e9,stroke:#d35400,stroke-dasharray: 5 5
    style G fill:#fdf2e9,stroke:#d35400,stroke-dasharray: 5 5
    style F1 fill:#fdf2e9,stroke:#d35400,stroke-dasharray: 5 5
Figure 1: Cohort Selection and Two-Tier Surgical Staging Classification

6. Defining URM

  • URM will be defined as anyone of hispanic ethnicity, black or AA, american indian or alaska native, native hawaiian or other pacific islander

  • Nonhispanic white- not hispanic, white race

  • Asian- not hispanic, Asian race


White   URM Asian  <NA> 
 1954   277    50   219 

7. Table 1: Demographics by Race

Manuscript-style Table 1:

Brief methods: Continuous variables were compared across racial and ethnic groups using one-way analysis of variance (ANOVA) or the Kruskal-Wallis test, while categorical variables were compared using Pearson’s chi-squared test or Fisher’s exact test (with Monte Carlo simulation across 10,000 replicates where expected cell counts were <5).

Table 1: Baseline Demographic and Clinical Characteristics Stratified by Race and Ethnicity

Characteristic

level

Overall

White

URM

Asian

p

test

n

2281

1954

277

50

Age at surgery, years (mean (SD))

42.85 (16.87)

43.21 (16.99)

40.36 (15.85)

42.49 (16.64)

0.030

Sex (%)

Female

631 (44.5)

540 (44.0)

80 (51.9)

11 (31.4)

0.049

Male

786 (55.5)

688 (56.0)

74 (48.1)

24 (68.6)

BMI, kg/m² (mean (SD))

25.42 (5.75)

25.37 (5.54)

26.27 (7.07)

22.71 (4.80)

<0.001

Diabetes mellitus (%)

Insulin

65 (2.8)

49 (2.5)

12 (4.3)

4 (8.0)

0.058

No

2140 (93.8)

1837 (94.0)

259 (93.5)

44 (88.0)

Non-Insulin

76 (3.3)

68 (3.5)

6 (2.2)

2 (4.0)

Hypertension requiring medication (%)

No

1920 (84.2)

1640 (83.9)

240 (86.6)

40 (80.0)

0.366

Yes

361 (15.8)

314 (16.1)

37 (13.4)

10 (20.0)

Current smoker (within 1 year) (%)

No

2150 (94.3)

1842 (94.3)

259 (93.5)

49 (98.0)

0.452

Yes

131 (5.7)

112 (5.7)

18 (6.5)

1 (2.0)

ASA classification (%)

ASA 1 - No Disturb

8 (0.4)

7 (0.4)

1 (0.4)

0 (0.0)

0.002

ASA 2 - Mild Disturb

1127 (49.4)

976 (49.9)

130 (46.9)

21 (42.0)

ASA 3 - Severe Disturb

1087 (47.7)

921 (47.1)

139 (50.2)

27 (54.0)

ASA 4 - Life Threat

56 (2.5)

49 (2.5)

6 (2.2)

1 (2.0)

ASA 5 - Moribund

2 (0.1)

0 (0.0)

1 (0.4)

1 (2.0)

None assigned

1 (0.0)

1 (0.1)

0 (0.0)

0 (0.0)

Biologic therapy (within 60 days) (%)

Cannot be determined

27 (1.3)

23 (1.3)

1 (0.4)

3 (6.5)

0.005

No

1129 (54.8)

964 (54.7)

135 (53.6)

30 (65.2)

Yes

904 (43.9)

775 (44.0)

116 (46.0)

13 (28.3)

Immunomodulator use (within 60 days) (%)

Cannot be determined

20 (1.0)

17 (1.0)

2 (0.8)

1 (2.2)

0.880

No

1839 (89.8)

1576 (90.0)

223 (89.2)

40 (87.0)

Yes

188 (9.2)

158 (9.0)

25 (10.0)

5 (10.9)

Elective surgery (%)

No

312 (22.9)

263 (22.2)

43 (30.1)

6 (17.6)

0.083

Yes

1048 (77.1)

920 (77.8)

100 (69.9)

28 (82.4)

Broad procedure category (Tier 1) (%)

TAC-EI

1095 (48.0)

919 (47.0)

156 (56.3)

20 (40.0)

0.015

RPC-IPAA

816 (35.8)

703 (36.0)

91 (32.9)

22 (44.0)

TPC-EI

370 (16.2)

332 (17.0)

30 (10.8)

8 (16.0)

Granular staged pathway (Tier 2) (%)

TAC-EI (Stage 1 Staged Colectomy)

966 (47.9)

812 (47.0)

137 (56.1)

17 (37.8)

0.002

exact (sim)

Classic 2-Stage RPC-IPAA

102 (5.1)

92 (5.3)

5 (2.0)

5 (11.1)

3-Stage Completion IPAA

616 (30.6)

523 (30.3)

78 (32.0)

15 (33.3)

1-Stage RPC-IPAA

5 (0.2)

4 (0.2)

0 (0.0)

1 (2.2)

Modified 2-Stage Completion IPAA

4 (0.2)

4 (0.2)

0 (0.0)

0 (0.0)

TPC-EI (Permanent Ostomy)

323 (16.0)

292 (16.9)

24 (9.8)

7 (15.6)

multivariable regression model for definitive surgery (TAC EI vs TPC EI/RPC IPAA)

Table 2: Multivariable Logistic Regression for Initial Staged Colectomy (TAC-EI) vs. Definitive Proctocolectomy
Characteristic OR 95% CI p-value
Race and ethnicity


    White — —
    URM 1.62 1.02, 2.56 0.040
    Asian 0.56 0.22, 1.33 0.2
Age at surgery, years 0.99 0.98, 1.00 0.017
Sex


    Female — —
    Male 1.07 0.81, 1.43 0.6
BMI, kg/m² 0.98 0.96, 1.01 0.2
Diabetes mellitus


    Insulin — —
    No 0.65 0.30, 1.44 0.3
    Non-Insulin 0.97 0.33, 2.84 >0.9
Hypertension requiring medication


    No — —
    Yes 1.11 0.70, 1.75 0.7
Current smoker (within 1 year)


    No — —
    Yes 1.52 0.83, 2.76 0.2
ASA classification


    ASA 1-2 — —
    ASA 3 1.41 1.04, 1.91 0.028
    ASA 4-5 4.72 1.37, 19.6 0.020
Biologic therapy (within 60 days)


    Cannot be determined — —
    No 0.04 0.00, 0.19 <0.001
    Yes 0.21 0.02, 1.08 0.094
Immunomodulator use (within 60 days)


    Cannot be determined — —
    No 5.49 1.20, 32.7 0.041
    Yes 14.2 2.89, 89.4 0.002
Elective surgery


    No — —
    Yes 0.08 0.05, 0.13 <0.001
Abbreviations: CI = Confidence Interval, OR = Odds Ratio

8. Unadjusted Outcomes for Postoperative Complications

Table 3: Unadjusted 30-Day Postoperative Outcomes Stratified by Race and Ethnicity (N = 2,281)

30-Day Outcome

Overall
N = 2,2811

White
N = 1,9541

URM
N = 2771

Asian
N = 501

p-value2

Composite 30-day complication (any)

444 (19.5%)

373 (19.1%)

62 (22.4%)

9 (18.0%)

0.4

Hospital length of stay, days

5.0 (3.0, 10.0)

5.0 (3.0, 9.0)

7.0 (4.0, 13.0)

5.0 (4.0, 8.0)

<0.001

Unknown

22

16

6

0

30-day unplanned readmission

366 (16.0%)

310 (15.9%)

47 (17.0%)

9 (18.0%)

0.8

Anastomotic leak

44 (1.9%)

38 (1.9%)

6 (2.2%)

0 (0.0%)

0.9

Unplanned return to OR

122 (5.3%)

106 (5.4%)

15 (5.4%)

1 (2.0%)

0.7

Bleeding requiring transfusion

131 (5.7%)

111 (5.7%)

17 (6.1%)

3 (6.0%)

0.9

30-day mortality

8 (0.4%)

8 (0.4%)

0 (0.0%)

0 (0.0%)

0.7

Superficial incisional SSI

77 (3.4%)

71 (3.6%)

5 (1.8%)

1 (2.0%)

0.3

Deep incisional SSI

10 (0.4%)

7 (0.4%)

2 (0.7%)

1 (2.0%)

0.10

Wound disruption / dehiscence

10 (0.4%)

9 (0.5%)

1 (0.4%)

0 (0.0%)

>0.9

Pneumonia

33 (1.4%)

26 (1.3%)

6 (2.2%)

1 (2.0%)

0.3

Unplanned intubation

16 (0.7%)

14 (0.7%)

2 (0.7%)

0 (0.0%)

>0.9

Pulmonary embolism

19 (0.8%)

18 (0.9%)

1 (0.4%)

0 (0.0%)

0.7

Ventilator > 48 hours

17 (0.7%)

14 (0.7%)

3 (1.1%)

0 (0.0%)

0.6

Progressive renal insufficiency

7 (0.3%)

7 (0.4%)

0 (0.0%)

0 (0.0%)

>0.9

Acute renal failure

3 (0.1%)

3 (0.2%)

0 (0.0%)

0 (0.0%)

>0.9

Urinary tract infection

30 (1.3%)

25 (1.3%)

5 (1.8%)

0 (0.0%)

0.7

Stroke / CVA

0

2,281 (100%)

1,954 (100%)

277 (100%)

50 (100%)

Myocardial infarction

0

2,281 (100%)

1,954 (100%)

277 (100%)

50 (100%)

Sepsis

92 (4.0%)

73 (3.7%)

16 (5.8%)

3 (6.0%)

0.2

Septic shock

32 (1.4%)

26 (1.3%)

6 (2.2%)

0 (0.0%)

0.4

DVT requiring therapy

49 (2.1%)

44 (2.3%)

3 (1.1%)

2 (4.0%)

0.2

1n (%); Median (Q1, Q3)

2Fisher's Exact Test for Count Data with simulated p-value
  (based on 10000 replicates); Kruskal-Wallis rank sum test; NA

9. Multivariable Regression Model for Postoperative Complications

Characteristic

OR

95% CI

p-value

Race and ethnicity

White

—

—

URM

1.30

0.84, 2.01

0.2

Asian

0.82

0.32, 2.11

0.7

Broad procedure category

TAC-EI

—

—

RPC-IPAA

0.99

0.66, 1.48

>0.9

TPC-EI

1.22

0.78, 1.89

0.4

Age at surgery (per year)

1.01

1.00, 1.02

0.2

Sex

Female

—

—

Male

1.00

0.75, 1.33

>0.9

BMI (per kg/m²)

1.01

0.99, 1.04

0.3

ASA classification

ASA 1-2

—

—

ASA 3

1.67

1.23, 2.28

0.001

ASA 4-5

3.82

1.65, 8.82

0.002

Elective surgery

No

—

—

Yes

0.46

0.32, 0.66

<0.001

Diabetes mellitus

No

—

—

Insulin

1.71

0.85, 3.46

0.13

Non-Insulin

0.79

0.35, 1.79

0.6

Hypertension requiring medication

No

—

—

Yes

1.13

0.75, 1.72

0.6

Current smoker (within 1 year)

No

—

—

Yes

0.61

0.31, 1.18

0.14

Biologic therapy (within 60 days)

No

—

—

Cannot be determined

1.86

0.47, 7.30

0.4

Yes

1.08

0.77, 1.50

0.7

Immunomodulator use (within 60 days)

No

—

—

Cannot be determined

0.92

0.25, 3.38

>0.9

Yes

0.69

0.41, 1.15

0.2

Abbreviations: CI = Confidence Interval, OR = Odds Ratio